HuMax-EGFR Uses, Dosage, Side Effects and more
HuMax-EGFR is a fully human IgG1 monoclonal antibody designed to bind with selectivity to the epidermal growth factor receptor (EGFR). HuMax-EGFR has been investigated for the treatment of Squamous Cell Cancer and Head and Neck Cancer.
| Attribute | Details |
|---|---|
| Trade Name | HuMax-EGFR |
| Generic | Zalutumumab |
| Zalutumumab Other Names | Zalutumumab |
| Type | |
| Formula | C6512H10074N1734O2032S46 |
| Weight | 146641.0546 Da |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
